Literature DB >> 4414178

Letter: Deanol: a solution for tardive dyskinesia?

E M Miller.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4414178     DOI: 10.1056/NEJM197410102911520

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  9 in total

1.  Deanol in tardive dyskinesia.

Authors:  L De Silva; C Y Huang
Journal:  Br Med J       Date:  1975-08-23

2.  The incorporation of monomethylethanolamine and dimethylethanolamine in fetal brain aggregating cell culture.

Authors:  F Dainous; J N Kanfer
Journal:  Neurochem Res       Date:  1988-01       Impact factor: 3.996

Review 3.  Antipsychotic drugs: clinical pharmacology and therapeutic use.

Authors:  J M Davis; R Casper
Journal:  Drugs       Date:  1977-10       Impact factor: 9.546

4.  Tardive dyskinesia treated with deanol acetamidobenzoate.

Authors:  I Ray
Journal:  Can Med Assoc J       Date:  1977-07-23       Impact factor: 8.262

Review 5.  Orofacial dyskinesia. Clinical features, mechanisms and drug therapy.

Authors:  R M Kobayashi
Journal:  West J Med       Date:  1976-10

6.  Treatment of neuroleptic induced tardive dyskinesia with cyproheptadine.

Authors:  K Kurata; K Hosokawa; Y Koshino
Journal:  J Neurol       Date:  1977-07-20       Impact factor: 4.849

7.  [Deanol in tardive dyskinesia: a double-blind study (author's transl)].

Authors:  S Bockenheimer; G Lucius
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1976-09-17

8.  2-dimethylaminoethanol (Deanol) in Huntington's chorea.

Authors:  T A Caraceni; F Girotti; I Celano; E Parati; L Balboni
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-12       Impact factor: 10.154

9.  Cholinergic inhibition of methylphenidate-induced stereotypy: oxotremorine.

Authors:  K L Davis; L E Hollister; J Tepper
Journal:  Psychopharmacology (Berl)       Date:  1978-01-31       Impact factor: 4.530

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.